Biosynthesis of elsamicin A, a novel antitumor antibiotic.

J Nat Prod

Bristol-Myers Company, Pharmaceutical Research and Development Division, Wallingford, Connecticut 06492.

Published: February 1990

The 1H noise-decoupled 13C-nmr spectrum of elsamicin A [1] prepared from the cultures of an unknown actinomycete species (ATCC 39417) supplemented with [1-13C]acetate and [2-13C]acetate showed enrichment of all 19-carbons in the aglycone. In addition, L-[methyl-13C]methionine- and D-[1-13C]glucose-supplemented cultures enriched the carbons of the two methyl groups on the disaccharide moiety and the C-1 carbons of the disaccharide, respectively. The results demonstrated that the aglycone of elsamicin A is derived entirely from acetate and the disaccharide portion is biosynthesized from two units of glucose and methionine.

Download full-text PDF

Source
http://dx.doi.org/10.1021/np50065a016DOI Listing

Publication Analysis

Top Keywords

biosynthesis elsamicin
4
elsamicin novel
4
novel antitumor
4
antitumor antibiotic
4
antibiotic noise-decoupled
4
noise-decoupled 13c-nmr
4
13c-nmr spectrum
4
spectrum elsamicin
4
elsamicin [1]
4
[1] prepared
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!